Digestive Disease Week 2010. Turning Science into Medicine--part 2.

The Digestive Disease Week 2010 conference, held in New Orleans, included topics covering new therapeutic developments in the field of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. This conference report highlights selected presentations on the apolipoprotein E-mimetic peptide COG-112 (Cognosci Inc) for the potential treatment of Citrobacter rodentium-induced colitis; the inhibition of sphingosine kinase with ABC-294640 (Apogee Biotechnology Corp) to alleviate stress after hepatic ischemia-reperfusion injury; TLR4 targeting with NI-0101 (NovImmune SA) to prevent colitis-associated cancer; immunization against TNF with TNFalpha kinoid (Neovacs SA) for the treatment of patients with Crohn's disease; and preclinical studies with the anti-inflammatory agent minnelide (University of Minnesota) for the treatment of pancreatic cancer.
AuthorsLisa Hodgkinson
JournalIDrugs : the investigational drugs journal (IDrugs) Vol. 13 Issue 7 Pg. 424-6 (Jul 2010) ISSN: 2040-3410 [Electronic] England
PMID20582861 (Publication Type: Congresses)
Chemical References
  • Drugs, Investigational
  • Animals
  • Clinical Trials as Topic
  • Digestive System Diseases (drug therapy, immunology, therapy)
  • Drug Evaluation, Preclinical
  • Drugs, Investigational (adverse effects, pharmacology, therapeutic use)
  • Humans
  • Immunization

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: